🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

European stocks rise; Rio Tinto up, Genmab slumps

Published 08/18/2009, 04:17 AM
Updated 08/18/2009, 04:21 AM
UK100
-
HSBA
-
BP
-
CSGN
-
TTEF
-
SAN
-
GMAB
-
XTA
-
ENRC
-
RIO
-
AAL
-
BHPB
-
ANTO
-
GC
-
HG
-

* FTSEurofirst 300 index up 0.7 percent

* Rio Tinto gains after Alcan unit sale

* Genmab slumps after drug trial disappoints

By Joanne Frearson

LONDON, Aug 18 (Reuters) - European shares were higher in early trade on Tuesday, with banks and commodity stocks gaining as investors awaited the release of German ZEW figures and U.S. housing starts later in the day.

By 0801 GMT, the pan-European FTSEurofirst 300 index of top shares was up 0.7 percent at 927.99 points. The index fell 2 percent on Monday, but has gained nearly 44 percent since reaching a lifetime low on March 9.

"We have the German ZEW Confidence figures (due at 0900 GMT) which are quite likely to be positive. The story of growing confidence in Germany will be treated with relief. ... If the ZEW are not upbeat, investors will be wary," said Justin Urquhart Stewart, director at Seven Investment Management.

The German ZEW current figure is seen down -85.0, better than -89.3 in July.

Banks added the most points to the index. HSBC Holdings was up nearly 3 percent after Goldman Sachs said HSBC's troubled U.S. unit will stop being a major drag on earnings earlier than expected. The broker upgraded the stock to 'buy' from 'neutral.

UniCredit, Banco Santander and Credit Suisse were up 0.8-1.8 percent.

Energy stocks were higher as crude steadied at $67 a barrel with the growth of Hurricane Bill offering some price support. BG Group, BP, Royal Dutch Shell and Total gained 0.4-0.7 percent.

RIO TINTO GAINS, SELLS ALCAN UNIT

Miners were on the upside. Rio Tinto rose 1.8 percent after agreeing to sell its Alcan packaging unit for about $2 billion to Australia's Amcor, easing its debt burden after an ill-timed acquisition two years ago.

The sector was supported by higher metal prices, copper gained 1.2 percent, aluminium was up 2.8 percent and nickel rose 2.1 percent.

Anglo American, Antofagasta, BHP Billiton, Eurasian Natural Resources Corporation and Xstrata were up 0.6-3.4 percent.

On the downside, drugmakers were in the doldrums. Danish biotech company Genmab slumped 30 percent after saying it would report a bigger loss in 2009 than initially expected after failing to get a hoped-for milestone payment in the wake of disappointing drug trial results.

Later in the session, investors will eye U.S. housing starts and building permits for July at 1230 GMT.

Economists in a Reuters survey forecast an increase to a 600,000 annualised rate from 582,000 in June, and a total of 580,000 building permits compared with 570,000 the prior month.

"U.S. housing starts will hopefully be showing positive figures. The market has got itself into a position now that it is expecting good news and anything that isn't good is likely to be greeted with severe concerns," said Urquhart Stewart.

Across Europe, the FTSE 100 index was up 0.8 percent ahead of British inflation date for July at 0830 GMT, while Germany's DAX and France's CAC 40 both gained 0.5 percent. (Reporting by Joanne Frearson; Editing by Dan Lalor)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.